Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1,079,784,035
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
49,991,144
-
Shares change
-
+10,622,918
-
Total reported value, excl. options
-
$253,404,020
-
Value change
-
+$54,026,855
-
Put/Call ratio
-
135%
-
Number of buys
-
65
-
Number of sells
-
46
-
Price
-
$5.07
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q4 2022
As of 31 Dec 2022 ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) had 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,991,144 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, CVI Holdings, LLC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, SHEETS SMITH WEALTH MANAGEMENT, JPMORGAN CHASE & CO, GOLDMAN SACHS GROUP INC, Balyasny Asset Management LLC, and PICTET ASSET MANAGEMENT SA.
This table shows 164 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.